Passive meets aggressive in Teva-Mylan talks - MarketWatch
Trump makes the case for chloroquine as a COVID-19 treatment, though it has not been approved by the FDA for this illness - MarketWatch
Teva releases generic version of Mylan's EpiPen in limited doses in the U.S. - MarketWatch
Is TEVA Stock A Buy or Sell?
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Israel stocks fall for fifth day; Teva rises - MarketWatch
Israel stocks at record; Biogen remarks cost Teva - MarketWatch
Drugmaker Teva Pharmaceuticals found guilty for contribution to opioid crisis - MarketWatch
Teva Pharmaceuticals - Wikipedia
Israel stocks tick lower; Teva, Itamar in focus - MarketWatch
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Mylan sees opportunity in rival Teva's weakness - MarketWatch
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
Israel stocks up, led by Teva, Bezeq - MarketWatch
Hedge Funds Are Dipping Their Toes Into Teva Pharmaceutical Industries (TEVA )
Mylan and Teva stocks rise on report about Amazon's pharmacy aims - MarketWatch
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
Israel stocks rise, led by Teva, ICL - MarketWatch
TEVA Gears Up to Report Q4 Earnings: What's in the Cards?
Teva Suffers Loss In New York's Opioid Trial
Is Teva Pharmaceutical (TEVA) a Good Stock to Pick Now?
